logo
Orient Electric shares gain over 2% after Q1 results; net profit rises 21% YoY to Rs 17.5 crore

Orient Electric shares gain over 2% after Q1 results; net profit rises 21% YoY to Rs 17.5 crore

Business Upturn3 days ago
By Aditya Bhagchandani Published on July 25, 2025, 13:57 IST
Shares of Orient Electric rose 2.09% to Rs 221.05 in Wednesday's trade following the announcement of its Q1 FY26 earnings. The stock moved up from its previous close of Rs 216.53 and hit an intraday high of Rs 224.95, supported by strong buying interest after the earnings release.
Orient Electric reported a modest rise in revenue and a strong increase in profitability for the quarter ended June 30, 2025. The company posted a total income of Rs 771.56 crore in Q1 FY26, up 1.9% from Rs 757.33 crore in the year-ago period.
Net profit surged 21% YoY to Rs 17.52 crore compared to Rs 14.34 crore in Q1 FY25, aided by improved cost efficiency. EBITDA stood at Rs 46 crore, up 15% from Rs 40 crore last year, while EBITDA margin expanded to 6% from 5.31%.
The company's market capitalization currently stands at Rs 47,890 crore, and the stock is trading near the upper range of its 52-week band of Rs 177.21 to Rs 297.10.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Ahmedabad Plane Crash
Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mondelez International (MDLZ): A Strong Contender Among Food Dividend Stocks
Mondelez International (MDLZ): A Strong Contender Among Food Dividend Stocks

Yahoo

time18 minutes ago

  • Yahoo

Mondelez International (MDLZ): A Strong Contender Among Food Dividend Stocks

Mondelez International, Inc. (NASDAQ:MDLZ) is included among the 10 Best Food Stocks with Dividends. A colourful array of products like candies, chocolates and gums on a supermarket shelf. Mondelez International, Inc. (NASDAQ:MDLZ), a major name in the snack food industry, is well known for owning popular chocolate brands like Oreo, Cadbury, Chips Ahoy!, Milka, and others. As of 2025, it held the second-largest share in the global chocolate market at 12.3%. Mondelez International, Inc. (NASDAQ:MDLZ) has also been growing its footprint in the health food space, responding to the increasing global focus on healthier eating. The company reported strong earnings in the first quarter of 2025. Its revenue was $9.3 billion, which showed a 1% growth from the same period last year. Mondelez International, Inc. (NASDAQ:MDLZ) offers a dividend as well, which it has steadily increased since becoming an independent company. The company's cash position is also strong, as it generated $1.1 billion in cash from operating activities and reported free cash flow of $0.8 billion. It also returned $2.1 billion to shareholders. It currently offers a quarterly dividend of $0.47 per share and has a dividend yield of 2.66%, as of July 27. While we acknowledge the potential of MDLZ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: READ NEXT: and Disclosure: None. Sign in to access your portfolio

Goldman Sees 11% Upside in China Stocks on Potential for US Deal
Goldman Sees 11% Upside in China Stocks on Potential for US Deal

Bloomberg

timean hour ago

  • Bloomberg

Goldman Sees 11% Upside in China Stocks on Potential for US Deal

Goldman Sachs Group Inc. raised its target for Chinese stocks, citing improving prospects for a US-China trade deal that would remove a key overhang for the market. Referring to trading patterns seen in other countries 'that have concluded trade agreements with the US in the past months, a potential US-China trade deal could be a market-clearing event for Chinese stocks,' strategists including Kinger Lau wrote in a note dated Monday.

Why are Laurus Labs shares up over 2% today? Explained
Why are Laurus Labs shares up over 2% today? Explained

Business Upturn

timean hour ago

  • Business Upturn

Why are Laurus Labs shares up over 2% today? Explained

By Aditya Bhagchandani Published on July 28, 2025, 09:27 IST Shares of Laurus Labs Ltd surged over 2% to ₹856.25 in early trade on Monday, making it one of the top gainers on the NSE. The sharp upmove comes on the back of a stellar Q1 performance, a major land allotment for expansion, and bullish commentary from top brokerages. Here's what's driving the stock higher: 1. Blockbuster Q1 FY26 Results Laurus Labs posted a net profit of ₹163 crore, up a massive 1,185% YoY from ₹13 crore a year ago. Revenue : ₹1,570 crore (up 31% YoY) : ₹1,570 crore (up 31% YoY) EBITDA : ₹389 crore (up 127% YoY) : ₹389 crore (up 127% YoY) EBITDA Margin: Expanded significantly YoY, reflecting strong operating leverage This marked the company's third consecutive earnings beat, with particularly robust performance in the CDMO (Contract Development and Manufacturing Organization) and ARV (antiretroviral) verticals. 2. Strategic Land Allotment for Laurus Pharma Zone The Andhra Pradesh government allotted 531.77 acres to Laurus in IP Rambilli Phase-II (Anakapalli District) for the development of a Laurus Pharma Zone (LPZ). Planned investment : ₹5,630 crore : ₹5,630 crore Job creation target : 6,350 people : 6,350 people Phased execution over 8 years This land is crucial for Laurus' long-term growth strategy, giving it the physical base to scale up manufacturing capabilities across API, formulations, and novel therapies. 3. Bullish Broker Commentary Motilal Oswal (MOSL) has maintained a 'Buy' rating, raising the target price to ₹970 (from ₹860) Upgraded gross margin guidance to 55–60% (from 50–55%) Strong CDMO visibility and pipeline Raised earnings estimates by 16% for FY26 and 7% for FY27 has maintained a rating, raising the (from ₹860) Antique Stock Broking gave a more balanced view, maintaining a 'Hold' but still raising the target to ₹700 (from ₹520), citing: Limited visibility in CDMO contracts ARV outlook steady but not exceptional Scale-up challenges in Bio CDMO segment gave a more balanced view, but still raising the target to ₹700 (from ₹520), citing: Still, the firm expects ~16% revenue CAGR from FY25 to FY28, and EBITDA margins to rise from 19% to 30% over the same period. Segmental Strength & Capex Plans The CDMO business is growing rapidly , now contributing more meaningfully to revenues , now contributing more meaningfully to revenues The company is also building a new Gene/ADC facility in Hyderabad and a microbial fermentation plant in Vizag and a Plans to invest ₹5,000 crore over the next 5 years, with net debt/EBITDA expected to stay in the 2.2x–2.5x range Market Snapshot: Stock Price : ₹856.25 (up 2.21%) : ₹856.25 (up 2.21%) 52-week range : ₹417.70 – ₹855.00 : ₹417.70 – ₹855.00 Market Cap : ₹460.32 billion : ₹460.32 billion P/E Ratio: 90.53 Laurus Labs' sharp rally today is driven by optimism around its blockbuster Q1 numbers, the government-backed land allotment, and analyst upgrades, all of which point to a long runway for growth. While near-term execution challenges remain, the market appears to be betting on Laurus' transformational expansion strategy and strong positioning in high-value pharma segments. Disclaimer: This article is for informational purposes only and should not be construed as investment advice. Please consult your financial advisor before making any investment decisions. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store